NOVEL CANNABINOID RECEPTOR 1 INVERSE AGONIST CRB-913 ENHANCES EFFICACY OF TIRZEPATIDE, SEMAGLUTIDE, AND LIRAGLUTIDEIN THE DIET-INDUCED OBESITY MOUSE MODEL

Descargar Publicación
Associations among prenatal exposure to gestational diabetes mellitus, brain structure, and child adiposity markers Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery